Literature DB >> 12037100

Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.

Sandra M Tallent1, Tammy Bischoff, Michael Climo, Belinda Ostrowsky, Richard P Wenzel, Michael B Edmond.   

Abstract

Nosocomial oxacillin-resistant Staphylococcus aureus (ORSA) bloodstream isolates were tested to determine the prevalence of vancomycin heteroresistance. We screened 619 ORSA nosocomial bloodstream isolates from 36 hospitals between 1997 and 2000. Only one isolate exhibiting heterotypic resistance was detected. Thus, vancomycin heteroresistance in clinical bloodstream isolates remains rare in the United States.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12037100      PMCID： PMC130823          DOI： 10.1128/JCM.40.6.2249-2250.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.

Authors:  G Bierbaum; K Fuchs; W Lenz; C Szekat; H G Sahl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

2.  Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.

Authors:  A Marchese; G Balistreri; E Tonoli; E A Debbia; G C Schito
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000.

Authors: 
Journal:  Am J Infect Control       Date:  2000-12       Impact factor: 2.918

4.  Evaluation of new medium, oxacillin resistance screening agar base, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens.

Authors:  A E Simor; J Goodfellow; L Louie; M Louie
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2000.

Authors:  T Fujino; N Mori; A Kawana; H Kawabata; T Kuratsuji; K Kudo; O Kobori; Y Yazaki; T Kirikae
Journal:  Jpn J Infect Dis       Date:  2001-04       Impact factor: 1.362

6.  Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals.

Authors:  O Chesneau; A Morvan; N E Solh
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

7.  Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.

Authors:  D Franchi; M W Climo; A H Wong; M B Edmond; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

Review 8.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

Authors:  S K Fridkin
Journal:  Clin Infect Dis       Date:  2000-12-13       Impact factor: 9.079

9.  Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.

Authors:  S K Hubert; J M Mohammed; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

10.  Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.

Authors:  J E Finan; G L Archer; M J Pucci; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191
View more
  9 in total

Review 1.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 2.  New antimicrobial agents as therapy for resistant gram-positive cocci.

Authors:  J R Lentino; M Narita; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01       Impact factor: 3.267

3.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.

Authors:  Thea Chua; Carol L Moore; Mary B Perri; Susan M Donabedian; William Masch; Dora Vager; Susan L Davis; Kaitlin Lulek; Benjamin Zimnicki; Marcus J Zervos
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

Review 4.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Authors:  Hong Bin Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria.

Authors:  Olajuyigbe Olufunmiso; Ikpehae Tolulope; Coopoosamy Roger
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

7.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

8.  Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Mitchell J Schwaber; Sharon B Wright; Yehuda Carmeli; Lata Venkataraman; Paola C DeGirolami; Aneta Gramatikova; Trish M Perl; George Sakoulas; Howard S Gold
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

Review 9.  Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.

Authors:  Shanshan Zhang; Xiaoxi Sun; Wenjiao Chang; Yuanyuan Dai; Xiaoling Ma
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.